|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Healthy | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Severe Acute Respiratory Syndrome | |||||
| 3 | More general conditions related to this trial | ||||
| Coronaviridae Infections | |||||
| Coronavirus Infections | |||||
| Nidovirales Infections | |||||
| Respiratory Tract Diseases | |||||
| Respiratory Tract Infections | |||||
| RNA Virus Infections | |||||
| Virus Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Blood Test | |||||
| Urine Test | |||||
| Physical Exam | |||||
| Vaccine | |||||
| VRC-SRSDNA015-00-VP | |||||
| 5 | Sponsors listed in this trial | ||||
| National Institute of Allergy and Infectious Diseases (NIAID) | |||||